We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

GALLANT 22 Tesaglitazar vs. Placebo

This study has been terminated.
(The development program has been terminated)
Sponsor:
ClinicalTrials.gov Identifier:
NCT00252837
First Posted: November 15, 2005
Last Update Posted: March 17, 2008
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
AstraZeneca
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: December 2006
  Primary Completion Date: No date given